Moderate AS in HFrEF: Time to Treat Is Now
Presenter:
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Grant Support/Research Contract - Edwards Lifesciences; Medtronic; Boston Scientific Corporation; PulseCath BV; Daiichi-Sankyo/Elil Lilly and Company; Abbott
- Consultant Fee/Honoraria/Speaker's Bureau - Boston Scientific Corporation; Daiichi-Sankyo/Elil Lilly and Company; Abbott; JenaValve; ANteris; Siemens Healthineers; Amgen
Video Player is loading.